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Acute lobar nephronia in children 177the majority of susceptibilities were similar in the ALN and APN groups. The majority of clinical
manifestations are nonspecific and unreliable for the differentiation of ALN and APN. The pa-
tients with ALN were febrile for longer after antimicrobial treatment, had more nausea/vom-
iting symptoms, higher neutrophil count, bandemia, and C-reactive protein (CRP) levels, and
lower platelet count (all p < 0.05). In multivariate analysis, initial CRP levels, nausea/vomiting
symptoms, and fever duration after admission were independent variables with statistical sig-
nificance to predict ALN. Severe nephromegaly occurred significantly more in the ALN group
than in the APN group (p Z 0.022).
Conclusion: The majority of clinical manifestations, laboratory findings, and microbiological
features are similar between patients with ALN and APN. Clinicians should keep a high index
of suspicion regarding ALN, particularly for those with ultrasonographic nephromegaly, initial
higher CRP, nausea/vomiting, and fever for > 5 days after antimicrobial treatment.
Copyright ª 2014, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
The clinical severity of acute renal bacterial infections
range from uncomplicated lower urinary tract infections
(UTI) to frank abscess formation.1 Among these renal in-
flammatory diseases, acute lobar nephronia (ALN), also
known as acute focal bacterial nephritis, is a non-
suppurative focal form of acute bacterial infection, gener-
ally affecting one or more renal lobules. The reported
incidence of ALN has increased as a result of advancements
in noninvasive imaging techniques,2e5 of which renal ultra-
sonography is considered to be the best and most effective
screening method. Computed tomography (CT) is currently
recognized as the most sensitive and specific imaging mo-
dality to diagnose ALN,1,3,4,6e9 which typically appears as
wedge-shaped, poorly defined regions of decreased neph-
rogenic density after contrast medium administration and as
mass-like hypodense lesions in the more severe form.1,7,8,10
The clinical presentations and laboratory findings are
similar between patients with ALN and acute pyelonephritis
(APN), and differentiation of ALN and APN is not easy in the
early stage of illness.5 However, effective antimicrobial
therapy for the treatment of ALN generally requires a longer
duration than treatment for uncomplicated APN, indicating
the importance of an adequate diagnosis.6,8,11 In addition,
ALN may also represent a relatively early stage of the
development of a renal abscess, and ALN is associated with a
very high incidence of renal scarring.6,12,13 Clinicians should
therefore have a high index of suspicion of ALN in patients
with UTI. In this study, we reviewed and compared the clin-
ical presentations, microbiological findings, and imaging
results of patientswith ALNandAPN in our hospital from1999
to 2012. The aim of this study was to provide an under-
standing of ALN in children by comparing the clinical mani-
festations, laboratory findings, imaging results, common
pathogens, and their antimicrobial susceptibilities, treat-
ments, andoutcomes of pediatric patientswithALNandAPN.
2. Methods
We retrospectively evaluated the medical records of 1039
pediatric patients (age  18 years) hospitalized for UTIfrom January 1999 to December 2012 at our hospital, a
1700-bed medical center in southern Taiwan providing both
primary and tertiary medical care. The majority of patients
received renal ultrasound or technetium-99m-labeled
dimercaptosuccinic acid (DMSA) renal scanning within 3
days of admission. CTwas performed when the patients had
a focal renal mass on renal ultrasound, or remained febrile
for 72 hours after susceptible antimicrobial treatment for
upper UTI as localized by DMSA or renal ultrasound. Renal
size was recorded by renal ultrasound, and the normal
sonographic values of kidney sizes among Taiwanese chil-
dren were adapted from the study by Chu et al.5,14 Severe
nephromegaly was defined as a kidney size 3 standard de-
viations larger than the mean.
The definition of ALN was based on positive CT findings
after contrast medium administration. Patients with
trauma, previous renal surgery, malignancy, and other
concomitant diagnoses that may have caused a fever, such
as acute gastroenteritis and balanoposthitis, were
excluded. In total, 80 patients fulfilled the enrollment
criteria of ALN, and all of them were enrolled in the ALN
group. In addition, each patient diagnosed with APN who
was matched for sex, age, and admission date to each ALN
patient was enrolled in the APN group. The definition of
APN was based on the admission diagnosis of UTI combined
with pelvic wall thickening and renal enlargement seen in
renal ultrasound, or the presence of focal or diffuse areas
of decreased uptake of DMSA without evidence of cortical
loss, or by the presence of diffusely decreased uptake in an
enlarged kidney. The medical records of all patients in both
groups were retrospectively reviewed with regard to their
demographic characteristics, clinical presentations, labo-
ratory findings, microbiological features, imaging results,
treatment, and outcomes.
The attending physicians made all decisions regarding
antimicrobial therapy, either prior to or after the results of
susceptibility tests. Renal sonography and DMSA renal scans
were performed as soon as possible after hospitalization,
usually within 3 days of admission. After complete treat-
ment, radionuclide cystography or voiding cystourethrog-
raphy was arranged for vesicoureteral reflux (VUR) studies.
Radiologists and nuclear medicine physicians reviewed the
imaging results.
178 W.-L. Chen et alAll statistical analyses were performed using SPSS
version 17.0 for Windows (SPSS Inc., Chicago, IL, USA). We
compared laboratory and clinical parameters to differen-
tiate ALN from APN in univariate and multivariate analysis.
The data are reported as the mean  standard deviation
where appropriate. Statistical comparisons of continuous
data between the different groups were performed using an
independent samples t test. For comparisons of nominal
data, c2 or Yate’s continuity correlation analysis was per-
formed where appropriate. Stepwise logistic regression was
used for multivariate analysis including significant variables
(p < 0.05) in univariate analysis. A binary logistic regression
analysis model was employed to estimate adjusted odds
ratios (aOR) and corresponding 95% confidence intervals
(CI) to compare ALN and APN in relation to clinical and
laboratory variables.3. Results
In total, among the 1039 pediatric patients who were
diagnosed as having UTI during the study period, 160 pa-
tients (80 with APN and 80 with ALN) were included in this
study. The demographic characteristics and clinical data of
the patients in these two groups are summarized in Table 1.Table 1 Comparison of demographic and clinical data betw
pyelonephritis.
Characteristic
ALN group (
Age (y) 5.10  4.97
Females 64 (80)
Previous UTI 11 (14)
Fever duration before hospitalization (d) 3.09  1.77
Fever duration after hospitalization (d) 4.85  2.33
Hospitalization duration (d) 21.79  11.
Clinical symptoms
Fever 79 (99)
Nausea/vomiting 32 (40)
Abdominal pain 24 (30)
Dysuria 12 (15)
Flank pain 8 (10)
Frequency 8 (10)
Diarrhea 6 (8)
Seizure 2 (3)
Shock 1 (1)
Laboratory data (serum)
WBC,  109 cells/L 17.7  7.2
Segment, % 69.8  14.2
Band, % 3.9  6.5
CRP, mg/dL 16.34  11.
Hemoglobin, g/dL 11.29  1.3
Platelet,  1012/L 284.10  96
Blood urea nitrogen, mg/dL 11.17  4.7
Creatinine, mg/dL 0.62  0.33
Data are mean  standard deviation or n (%) of the indicated charac
*p < 0.05.
ALNZ acute lobar nephronia; APNZ acute pyelonephritis; CRPZ C-r
cell count.CT scans indicated that 33 patients had right ALN, 21 pa-
tients had left ALN, and 26 patients had bilateral ALN. Of
the patients with ALN, 17 had complicated ALN on CT, as
seen by lesions consistent with heterogeneously decreased
nephrographic density after contrast medium enhance-
ment. The other 63 patients had simple ALN on CT, which
appeared as striated or wedge-shaped, poorly defined re-
gions of homogenously decreased nephrographic density
after contrast medium administration. Only one patient in
the APN group received a CT scan, which revealed no evi-
dence of ALN. The fever duration after hospitalization days
in the ALN group was 4.85  2.33 days. By contrast, the
fever duration after hospitalization days in the APN group
was only 2.30  1.47 days. The patients with ALN were
febrile for longer after hospitalization (p < 0.001) and had
more nausea/vomiting symptoms (p Z 0.006) than those
with APN. A higher neutrophil count (p Z 0.047), higher
bandemia (p Z 0.034), higher C-reactive protein (CRP)
levels (p < 0.001), and lower platelet count (p Z 0.01)
were also noted for the patients diagnosed with ALN. The
other demographic characteristics were similar between
the two groups.
The microbiological findings and imaging results be-
tween the two groups are summarized in Table 2. Urine
cultures were performed in 157 patients (79 in the ALNeen the children with acute lobar nephronia and acute
No. (%) of patients p
n Z 80) APN group (n Z 80)
4.87  4.88 0.77
64 (80) 1
10 (13) 0.815
2.96  2.93 0.74
2.30  1.47 <0.001*
55 8.94  3.41 <0.001*
76 (95) 0.363
16 (20) 0.006*
17 (21) 0.205
15 (19) 0.527
11 (14) 0.463
9 (11) 0.798
4 (5) 0.744
1 (1) 1.000
0 1.000
15.6  6.4 0.059
64.7  17.8 0.047*
2.0  4.6 0.034*
27 8.77  8.75 <0.001*
6 11.69  1.56 0.083
.53 327.64  113.05 0.01*
5 11.08  5.4 0.925
0.59  0.24 0.496
teristic.
eactive protein; UTIZ urinary tract infection; WBCZ white blood
Table 2 Comparison of microbiological findings and imaging results between the children with acute lobar nephronia and
acute pyelonephritis.
Characteristic No. (%) of patients p
ALN group (n Z 80) APN group (n Z 80)
Microbial findings
Urine culture 79 (99) 78 (98) NS
No finding 30 (38) 35 (44) NS
Escherichia coli 44 (55) 37 (46) NS
Proteus mirabilis 1 (1) 3 (4) NS
Klebsiella pneumoniae 2 (3) 0 NS
Pseudomonas aeruginosa 1 (1) 1 (1) NS
Staphylococcus saprophyticus 1 (1) 0 NS
Streptococcus viridans 0 1 (1) NS
Enterococcus aerogenes 0 1 (1) NS
Morganella morganii 0 1 (1) NS
Blood culture 80 (100) 78 (98) NS
No finding 76 (95) 78 (98) NS
E. coli 4 (5) 0 NS
Image findings
Ultrasonographic findings*
Severe nephromegaly 34 (44) 21 (27) 0.022
Severe nephromegaly without focal mass 25 (33) 21 (27) NS
Severe nephromegaly with focal mass 9 (12) 0 (0) NS
Focal mass without severe nephromegaly 9 (12) 0 (0) NS
Neither severe nephromegaly nor focal mass 34 (44) 58 (73) NS
Decreased uptake in DMSAy 71 (96) 67 (93) NS
DRC or VCUGz
Normal 55 (82) 50 (77) NS
Grade IeIII VUR 6 (9) 8 (12) NS
Grade IVeV VUR 6 (9) 7 (11) NS
ALN Z acute lobar nephronia; APN Z acute pyelonephritis; DMSA Z dimercaptosuccinic acid; DRC Z radionuclide cystography;
NS Z not significant; VCUG Z voiding cystourethrography; VUR Z vesicoureteral reflux.
* Data were available in 77 patients in the ALN group and 79 patients in the APN group, severe nephromegaly was defined as a renal
length of 3 standard deviations greater than the mean for age.
y Data were available in 74 patients in the ALN group and 72 patients in the APN group.
z Data were available in 67 patients in the ALN group and 65 patients in the APN group.
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(30 in the ALN group and 35 in the APN group) had no
apparent organism that could be isolated from urine cul-
ture, and 92 had positive urine cultures. Among these 92
patients, Escherichia coli was the most common urinary
pathogen (n Z 81, including 44 in the ALN group and 37 in
the APN group), followed by Proteus mirabilis (n Z 4),
Klebsiella pneumoniae and Pseudomonas aeruginosa (nZ 2
each), Staphylococcus saprophyticus, Streptococcus vir-
idans, Enterococcus aerogenes, and Morganella morganii
(nZ 1 each). Only one patient with APN had urine cultures
with mixed bacterial growth, composed of E. coli and
P. mirabilis. Positive blood cultures were noted in four
patients, all of whom were in the ALN group, and all were
caused by E. coli.
Compared with the APN group, E. coli isolated from the
urine cultures in the ALN group had a similarly high resis-
tance rate to ampicillin (68% vs. 62%, p Z 0.57), but a
higher resistance rate to trimethoprimesulfamethoxazole
(59% vs. 27%, p Z 0.004) and piperacillin (77% vs. 54%,
pZ 0.027). Although we used cefazolin and/or gentamicinas the empirical therapy for pediatric UTI from 2000,15,16
the resistance rate to cefazolin (24% in ALN vs. 21% in
APN, pZ 0.611) and gentamicin (27% in ALN vs. 24% in APN,
p Z 0.626) did not increase significantly. Only three pa-
tients (2 in the ALN group and 1 in the APN group) with
E. coli isolated from their urine cultures had resistance
to both cefazolin and gentamicin. However, extended-
spectrum b-lactamase (ESBL)-producing organisms were
found in three E. coli isolations, including two in the ALN
group and one in the APN group, all of which were isolated
after 2010.
Among the 160 patients, 74 in the ALN group and 72 in
the APN group underwent DMSA renal scans, and 77 patients
in the ALN group and 79 in the APN group underwent renal
sonography. There was no difference in the DMSA findings
between the two groups (p Z 0.97). When using the defi-
nition of severe nephromegaly to define ALN as a renal
length of 3 standard deviations greater than the mean for
age,5 severe nephromegaly occurred significantly more
frequently in the ALN group than in the APN group (34 pa-
tients vs. 21 patients, p Z 0.022). A renal focal mass was
180 W.-L. Chen et alfound sonographically in 18 patients in the ALN group. None
of the patients had any evidence of underlying diseases
such as diabetes or immunodeficiency, neurogenic bladder,
or upper or lower urinary tract obstructions. Among the 160
patients in the two groups, 132 (67 in the ALN group and 65
in the APN group) underwent VUR studies after complete
treatment, including 100 radionuclide cystography, 17
voiding cystourethrography, and 15 for both. Twelve
(17.9%) patients in the ALN group and 15 (23.1%) patients in
the APN group had VUR, among whom a Grade IV or greater
was noted in six patients in the ALN group and seven in the
APN group. Most patients (84.6%, 11/13) who had severe
VUR (Grade IV or V) were younger than 5 years. Among the
patients who underwent VUR studies, no difference in
either frequency or severity of VUR was found between the
two groups.
All children received cefazolin and/or gentamicin
initially, and treatment was modified according to culture
results and clinical response. Sixty-seven children in the
APN group received intravenous antibiotic treatment with
cefazolin and/or gentamicin, compared to only 23 patients
in the ALN group. The other 57 children in the ALN group
received modified intravenous antimicrobial treatment,
including cefazolin plus amikacin (nZ 27), third generation
cephalosporins (n Z 22), and others (n Z 8). There was no
statistical difference in the number of hospitalization days
between the patients receiving different antimicrobial
regimens (cefazolin þ gentamicin: 21.5  13.2 days;
cefazolin þ amikacin: 22.9  8.4; third generation cepha-
losporins: 18.8  5.3days; other antibiotics: 22.8 9.5 days;
p Z 0.498). The duration of hospitalization in the ALN
group was 21.79  11.55 days, with 21.34  9.5 days of
intravenous antimicrobial treatment. By contrast, the
duration of hospitalization in the APN group was only
8.94  3.41 days, with 7.96  3.16 days of intravenous
antimicrobial treatment. This difference was significant
(p < 0.001). No cases of mortality were found in either
group. Only one previously healthy 10-year-old girl pro-
gressed to septic shock after initial admission and was
admitted to an intensive care unit for 3 days. She recovered
well later after antimicrobial treatment.
Univariate analysis revealed statistically significant dif-
ferences (p < 0.05) in fever duration after hospitalization,
nausea/vomiting symptoms, segment, band, CRP, platelet,
and severe nephromegaly in ultrasonographic findings be-
tween the ALN and APN groups. These independent vari-
ables were then used in stepwise logistic regression for
multivariate analysis, and there were three independent
variables with statistical significance to predict ALN in lo-
gistic multivariate analysis, which were initial serum CRP
(aOR, 1.06; 95% CI, 1.02e1.10), nausea/vomiting symptoms
(aOR, 2.65; 95% CI, 1.05e6.68), and fever duration after
hospitalization (aOR, 2.07; 95% CI: 1.57e2.72).4. Discussion
ALN was not uncommon in our series, with an incidence of
7.7% in patients with UTI, which is similar to a report by
Cheng et al9 conducted in northern Taiwan (8.6%). How-
ever, Yang et al17 reported the incidence of ALN to be as
high as 19.2% in children with a first-episode of febrile UTI.ALN is therefore not a rare condition, and it is probably an
underdiagnosed disease entity.18
Whether ALN presents as an early stage of renal abscess
is controversial.5,6,9,12,13,19,20 However, the evolution of
ALN into a renal abscess and an association with a very high
incidence of renal scarring has been reported.4,6,12,13,18
Therefore, it is extremely important to differentiate ALN
from APN, not only because these two conditions are
pathologically different, but also because ALN may be best
managed by a longer duration of antimicrobial treatment
than APN. In general, a total of 2e3 weeks of antimicrobial
therapy tailored to the urinary pathogen is recommended
for patients with ALN.4,6e8,19,21 By contrast, uncomplicated
APN has been reported to be best managed with a 10e14-
day course of antimicrobial treatment.22 Similar to the re-
ports by Cheng et al19 and Klar et al,6 most young children
in our series who were diagnosed with ALN presented with
nonspecific symptoms such as vomiting, diarrhea, and
abdominal pain, which could easily be thought to be asso-
ciated with other more common diseases.18 Dysuria was
present in 12 patients, and moreover, specific symptoms
such as flank pain were found only in older children with a
mean age of 12.6 years, which highlights that routine urine
examinations should be arranged for children with fever of
unknown origin.
There were three independent variables with statistical
significance to predict ALN in logistic multivariate analysis,
including initial serum CRP, nausea/vomiting symptoms,
and fever duration after hospitalization. However, these
parameters are all nonspecific and unreliable for differen-
tiation of infection sources, and, additionally, fever dura-
tion after hospitalization is not helpful for clinicians to
make a decision upon admission of children. From this point
of view, clinicians should keep a particularly high index of
suspicion for complicated UTI, especially for those with
initial higher CRP, nausea/vomiting symptoms, and longer
duration of fever after antimicrobial treatment during
hospitalization.
CT is considered the most sensitive and specific imaging
modality for ALN.1,4,6e8,19 However, it is expensive and
requires sedation for young patients.4,5 Sonography remains
the initial study of choice because of its noninvasive na-
ture, lack of ionizing radiation, and ability to detect in-
flammatory lesions and any congenital abnormalities.5,8 In
our series, severe nephromegaly occurred significantly
more in the ALN group than in the APN group (p Z 0.022).
Similar to Cheng et al,5 CT was not performed in our series
for the majority of the APN group since they did not have a
focal renal mass on sonography or their fever subsided after
72 hours of susceptible antimicrobial treatment. Since
antimicrobial susceptibility tests usually take 48 hours, the
findings are generally compatible with the modified rec-
ommendations from another study by Cheng et al9 in that
the use of CT can be reduced and limited to the patients
with UTI, ultrasonographic nephromegaly, and a fever for >
5 days after antimicrobial treatment.
The microbiological distributions were similar in the ALN
and APN groups. Among the 160 patients in this study,
E. coli was the most common pathogen cultured from urine
samples (81/92), which is consistent with the results of
previous studies.6,8,18,19 Bacteremia accounted for four
(5%) of 80 episodes in our ALN group, which is similar to
Acute lobar nephronia in children 181other studies that reported rates of 4e6%.6,18,19 The prev-
alence of ESBL-producing Enterobacteriaceae is increasing
rapidly worldwide.23 ESBL-producing organisms were found
in three (3.7%) E. coli isolates in our study, and all were
isolated after 2010. Similar to our ALN patients, a preva-
lence rate of 4.4% of ESBL-producing E. coli strains in UTI of
infants aged < 4 months was reported in our hospital from
2001 to 2009.15 It seems that ESBL E. coli is not related to
severity of UTI. However, few samples of ESBL E. coli were
present in our series. Therefore, further systemic studies
are needed, as well as long-term follow-up.
The duration of treatment for ALN is controversial. A
2e3-week course of antimicrobial therapy has been sug-
gested in recent prospective studies.19,20,24 In our series,
the majority (71%) of the ALN patients received modified
intravenous antimicrobial treatment for an average of
21.3  9.5 days, which led to a longer hospital stay. Further
studies are warranted to elucidate the potential benefits of
a longer or shorter duration of intravenous treatment for
ALN.
In our series, the prevalence of VUR among the patients
with ALN was similar to the previously reported prevalence
of VUR among the patients with UTI in our hospital.16 There
was no difference in the frequency or severity of VUR be-
tween the ALN and APN groups in our series. As reported by
Cheng et al,19 VUR may not be a prerequisite for the
development of ALN.
There are some limitations to this study that should be
highlighted. Our data come from a single medical center
in southern Taiwan, and therefore the results should not
be applied generally because of geographic diversity. In
addition, only one patient in the APN group received a CT
scan, and the detailed condition of those who did not
receive CT scans in the APN group is not clear. Twenty-one
of the 80 APN cases in our study had severe nephromegaly
on sonography, but without further CT data they were
classified into the APN group based simply on their faster
clinical response to antimicrobial treatment. This further
highlights the difficulty for clinicians to differentiate ALN
from APN without CT. Current knowledge on the clinical
diagnosis of ALN is still limited, and further studies are
warranted that should include long-term follow-up and
more detailed imaging data such as CT scans. In addition,
radionuclide cystography imaging was used for the diag-
nosis of VUR in the majority of our patients in the study.
This method is unable accurately to delineate the
detailed changes of the structure of the collecting system
in order to grade appropriately, and it cannot perform
correct VUR grading, both of which could affect the
results.
In conclusion, ALN is not a rare condition. However, the
majority of clinical manifestations are nonspecific and un-
reliable for the differentiation of ALN and APN. The
microbiological distributions were similar in the ALN and
APN groups. Cefazolin and gentamicin are still generally
sensitive in both groups, although they have been the first-
line empirical antimicrobial agents for > 1 decade. Clini-
cians should maintain a high index of suspicion towards
ALN, particularly for those patients with ultrasonographic
nephromegaly, initial higher CRP, nausea/vomiting symp-
toms, and a fever for > 5 days after receiving antimicrobial
treatment during hospitalization.Conflicts of interest
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